Metabolism. 1990 Apr;39(4 Suppl 1):3-9.

Osteoporosis and the metabolites of vitamin D.

Source

Department of Biochemistry, University of Wisconsin-Madison 53706.

Abstract

Vitamin D is metabolized by sequential steps in the liver and kidney to its active form, a process that is strongly feedback-regulated. In old age, the activity of the enzyme, 25-hydroxyvitamin D 1 hydroxylase, which produces the vitamin D hormone, is diminished. The activities of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) extend beyond increasing intestinal absorption of calcium. The vitamin D hormone (or its analogs) is useful in the treatment of osteoporosis because it not only stimulates intestinal calcium absorption, but also is required for the stimulation of osteoblasts and many other cells in the body. Recent work demonstrates that it is possible to chemically synthesize analogs selective for specific actions of the vitamin D hormone, especially in inducing differentiation of promyelocytes and keratinocytes.

PMID:: 2157943; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

DK-14881/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

1,25-DIHYDROXYCHOLECALCIFEROL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Vitamin D: recent advances. [Annu Rev Biochem. 1983]
Review Vitamin D: recent advances.
DeLuca HF, Schnoes HK. Annu Rev Biochem. 1983; 52:411-39.
Review The metabolism and functions of vitamin D. [Adv Exp Med Biol. 1986]
Review The metabolism and functions of vitamin D.
DeLuca HF. Adv Exp Med Biol. 1986; 196:361-75.
Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. [Cancer Res. 1993]
Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW, Sergeev IN, Bishop JE, Okamura WH. Cancer Res. 1993 Sep 1; 53(17):3935-42.
Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. [Endocrinology. 1985]
Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM, Hirst MA, Feldman D. Endocrinology. 1985 Nov; 117(5):2203-10.
Review Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. [Calcif Tissue Int. 1999]
Review Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.
Lau KH, Baylink DJ. Calcif Tissue Int. 1999 Oct; 65(4):295-306.

See reviews... See all...

Cited by 1 PubMed Central article

An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome. [Int J Med Sci. 2004]
An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome.
Annapoorna N, Rao GV, Reddy NS, Rambabu P, Rao KR. Int J Med Sci. 2004; 1(3):152-164. Epub 2004 Aug 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Osteoporosis and the metabolites of vitamin D.
Osteoporosis and the metabolites of vitamin D.
Metabolism. 1990 Apr ;39(4 Suppl 1):3-9.

PubMed
Ethyl 1-sec-butyl-2-(2-hydroxy-phen-yl)-1H-benzimidazole-5-carboxyl-ate 0.25-hyd...
Ethyl 1-sec-butyl-2-(2-hydroxy-phen-yl)-1H-benzimidazole-5-carboxyl-ate 0.25-hydrate.
Acta Crystallogr Sect E Struct Rep Online. 2010 May 8 ;66(Pt 6):o1285-6.

PubMed
N-Benzyl-N-methyl-3-phenyl-3-[4-(tri-fluoro-meth-yl)phen-oxy]propanamine (N-benz...
N-Benzyl-N-methyl-3-phenyl-3-[4-(tri-fluoro-meth-yl)phen-oxy]propanamine (N-benzylflouoxetine).
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 24 ;66(Pt 5):o1146.

PubMed
(S)-6-Chloro-4-cyclo-propyl-ethynyl-4-trifluoro-methyl-1H-3,1-benzoxazin-2(4H)-o...
(S)-6-Chloro-4-cyclo-propyl-ethynyl-4-trifluoro-methyl-1H-3,1-benzoxazin-2(4H)-one.
Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 21 ;65(Pt 12):o3170-1.

PubMed
Senile dementia of Lewy body type. A clinically and neuropathologically distinct...
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.
J Neurol Sci. 1990 Feb ;95(2):119-39.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: